Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience.

Authors :: Porrazzo M
Moscato T
Sapienza G
Accardi F
Patti C
Cangialosi C
Costanza C
Bono R
Tringali S
Rotolo C
Gigliotta E
Rizzuto A
Ingrascè MG
Butera G
Di Noto L
Santoro A
Marfia A
Botta C
Siragusa S
Martino M
Castagna L
Source :: Haematologica [Haematologica] 2024 Oct 31. Date of Electronic Publication: 2024 Oct 31.
Publication Year :: 2024
Publisher :: Ahead of Print
Abstract: Not available.

Full Text Access

Tools